APA (7th ed.) Citation

NC, G., I, X., MAG, S., NMA, Y., D, I. Ö., E, R., . . . R, S. (2025). Nanostructured Lipoxin A4: Understanding Its Biological Behavior and Impact on Alzheimer's Disease (Proof of Concept). Pharmaceutics, 17(5), . https://doi.org/10.3390/pharmaceutics17050649

Chicago Style (17th ed.) Citation

NC, Gomes-da-Silva, et al. "Nanostructured Lipoxin A4: Understanding Its Biological Behavior and Impact on Alzheimer's Disease (Proof of Concept)." Pharmaceutics 17, no. 5 (2025). https://doi.org/10.3390/pharmaceutics17050649.

MLA (9th ed.) Citation

NC, Gomes-da-Silva, et al. "Nanostructured Lipoxin A4: Understanding Its Biological Behavior and Impact on Alzheimer's Disease (Proof of Concept)." Pharmaceutics, vol. 17, no. 5, 2025, https://doi.org/10.3390/pharmaceutics17050649.